Pelvic Mesh Complications · Management

Step-by-step decision

Choose step by step as prompted; reaching an endpoint gives the management recommendation. You can go back a step or restart anytime.

🎓 Want to practice? Do a case challenge with this pathway → (get a case, choose management step by step, scored).

Full pathway

1. [Decision] Complication type + symptoms + mesh location/material
   Complication type? Symptoms? Mesh location (transvaginal/abdominal) and material (monofilament/multifilament)? (FDA reclassified transvaginal POP mesh to Class III and stopped its sale in 2019; abdominal sacrocolpopexy mesh and midurethral slings for stress incontinence remain in use. ICS/IUGA report by CTS (category-time-site) classification.)
   • Asymptomatic, monofilament mesh, small vaginal exposure → Asymptomatic small exposure → observe + topical estrogen
   • Symptomatic vaginal exposure/extrusion (bleeding/discharge/pain/dyspareunia) → Symptomatic vaginal exposure → transvaginal partial excision
   • Predominant chronic pelvic pain/dyspareunia (no obvious exposure) → Chronic pelvic pain/dyspareunia → multidisciplinary
   • Erosion into bladder/urethra/bowel or fistula formation → Visceral erosion/fistula → excision + organ repair
   • Mesh infection/abscess → Infection/abscess → antimicrobials + excision
2. [End] Asymptomatic small exposure → observe + topical estrogen
   Asymptomatic, monofilament mesh small exposure → conservative observation + vaginal topical estrogen to promote mucosal coverage; periodic review; manage if it persists/becomes symptomatic.
3. [End] Symptomatic vaginal exposure → transvaginal partial excision
   Symptomatic vaginal exposure/extrusion → transvaginal excision of the exposed mesh segment (partial excision); refer to an experienced pelvic floor reconstructive (FPMRS) surgeon; multifilament mesh or transvaginal failure → abdominal/laparoscopic revision with wider excision.
4. [End] Chronic pelvic pain/dyspareunia → multidisciplinary
   Chronic pelvic pain/dyspareunia (multifactorial) → multidisciplinary assessment (pain, pelvic floor physiotherapy, neurology); new apical pain after sacrocolpopexy may need complete mesh excision for relief; individualized, full informed consent on excision extent and recurrence risk.
5. [End] Visceral erosion/fistula → excision + organ repair
   Erosion into bladder/urethra/bowel or fistula formation → surgical excision of the involved mesh + organ repair (usually abdominal/laparoscopic, with transvaginal/cystoscopic/colorectal as needed), healthy tissue flap interposition; manage along the vesicovaginal/rectovaginal fistula pathway.
6. [End] Infection/abscess → antimicrobials + excision
   Mesh infection/abscess → antimicrobials + drainage + excision of the infected mesh (a foreign body is hard to clear with antibiotics alone); reassess pelvic floor reconstruction after infection control.

Source guidelines & references

• Mesh and graft complication management (ACOG committee opinion; IUGA/ICS CTS classification; FDA 2019 transvaginal POP mesh withdrawal)

This pathway is our own synthesis of the decision logic in the guidelines above (not the guideline verbatim); thresholds and workflows change as guidelines update — in practice follow the latest guideline, your institution's protocol and the individual patient.

Other pathways